The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease. (2021)

First Author: Qarin S
Attributed to:  The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/ns20200083

PubMed Identifier: 34552761

Publication URI: http://europepmc.org/abstract/MED/34552761

Type: Journal Article/Review

Volume: 5

Parent Publication: Neuronal signaling

Issue: 3

ISSN: 2059-6553